General form of registration statement for all companies including face-amount certificate companies

Intangible Assets, Net

v3.5.0.2
Intangible Assets, Net
6 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]    
Intangible Assets, Net

NOTE 4 – INTANGIBLE ASSETS, net

 

Intangible assets, net, consists of the following as of:

 

    June 30, 2016     December 31, 2015  
Patents   $ 432,985     $ 432,820  
Less accumulated amortization     (229,626 )     (217,342 )
      203,359       215,478  
Patents pending     228,826       209,019  
Total intangible assets, net   $ 432,185     $ 424,497  

 

Patents are amortized straight-line over a period of fifteen years. Amortization expense was $6,142 and $12,284, for the three and six-months ended June 30, 2016, respectively, and $2,708 and $11,662, for the three and six-months ended June 30, 2015, respectively.

 

The Company has capitalized costs for several patents that are still pending. In those instances, the Company has not recorded any amortization. The Company will commence amortization when these patents are approved.

 

The Company owns 21 issued patents, including 14 in the United States and 7 others in China, India, Japan, and Hong Kong. These patents will expire during the years of 2023 to 2028, subject to any patent term extensions of the individual patent. The Company has 5 foreign patent applications pending in Europe, Canada, and Brazil.

NOTE 5 – INTANGIBLE ASSETS, net

 

Intangible assets, net, consists of the following as of:

 

    December 31, 2015     December 31, 2014  
Patents   $ 432,820     $ 393,370  
Less accumulated amortization     (217,342 )     (200,272 )
      215,478       193,098  
Patents pending     209,019       226,420  
Total intangible assets, net   $ 424,497     $ 419,518  

 

Patents are amortized straight-line over a period of fifteen years. Amortization expense was $17,070 and $31,909, for the years ended December 31, 2015 and 2014, respectively.

 

The Company has capitalized costs for several patents that are still pending. In those instances, the Company has not recorded any amortization. The Company will commence amortization when these patents are approved.

 

The Company owns 21 issued patents, including 14 in the United States and 7 others in China, India, Japan, and Hong Kong. These patents will expire during the years of 2023 to 2028, subject to any patent term extensions of the individual patent. The Company has 5 foreign patent applications pending in Europe, Canada, and Brazil.